Background recent studies have revealed that (pro)renin receptor ((P)rr), a newly identified member of the renin-angiotensin system (raS), is associated with blood pressure regulation in animals. however, there is no information on (P)rr in humans. We investigated the association of (P)RR gene polymorphisms with blood pressure in a Japanese population.
Methods Subjects (n = 1,112) were recruited from participants in the Ohasama study, a Japanese cohort study. For the association study, we selected three polymorphisms: −782a>G (rs2968915), intervening sequence (IVS)5+169c>T (rs5918007), and +1513a>G (rs6609080). Because the (P)RR gene is on the X chromosome, men (n = 357) and women (n = 755) were analyzed separately.
results
In men, 24-h systolic blood pressure (SBP) and diastolic blood pressure (DBP) values, daytime SBP and DBP values, and nighttime SBP and DBP values were significantly higher in IVS5+169T allele carriers than c allele carriers. Multiple regression analysis showed that IVS5+169c>T was significantly and independently related to ambulatory blood pressure (aBP). IVS5+169c>T was not associated with casual blood pressure (cBP) in men. In women, there were no significant differences in blood pressure values among the three genotypes of IVS5+169c>T. This polymorphism had no significant association with any other clinical characteristic. −782a>G was weakly associated with aBP in men. +1513a>G was not associated with blood pressure values in either men or women.
conclusions
We demonstrated for the first time that polymorphism of the (P) RR gene IVS5+169c>T is associated with aBP in Japanese men. This association suggests that (P)rr has a role in blood pressure regulation. articles (Pro)renin Receptor and Blood Pressure blood pressure (DBP) in a genome wide association study. 21 However, there are no databases or reports showing an association between the (P)RR gene polymorphism and hypertension in humans. We investigated the association between (P)RR gene polymorphisms and blood pressure levels in a Japanese population.
Methods
Design and study population. This study was performed as part of the Ohasama study and based on data obtained from subjects who participated in our blood pressure monitoring and genetic analysis project in a rural community of Ohasama, Iwate prefecture, Japan. The characteristics of this area and details of the study design are described elsewhere. 22, 23 The study protocol, including the genetic analysis, was approved by the Institutional Review Board of Tohoku University School of Medicine and by the Department of Health of the Ohasama Town Government.
The population of Ohasama in 1998 was 7,202. Of those, 1,826 subjects gave written informed consent for blood pressure measurements and genetic analysis. All subjects were aged ≥40 years. Of the 1,826 subjects, 388 subjects were excluded because ambulatory blood pressure (ABP) values were not measured. Of the remaining 1,438 subjects, 326 subjects who lacked full data on clinical characteristics, blood pressure values, or information on genotypes were also excluded. As a result, 1,112 subjects (357 men and 755 women; mean age, 58.9 ± 10.1 years) were included in the study.
Blood pressure and biochemical measurements. Details of ABP monitoring have been described previously. 23, 24 In brief, ABP was monitored every 30 min using a fully automatic device (ABPM 630; Nippon Colin, Komaki, Japan). Mean 24-h, daytime, and nighttime values for ABP were calculated for each participant. "Daytime" and "nighttime" were determined according to each participant's diary. We thus analyzed ABP data obtained during >6 h of daytime and >3 h of nighttime. The mean number of measurements was 44.4 ± 4.8.
Casual blood pressure (CBP), measured by public health nurses or technicians using an automatic device (HEM 907; Omron Healthcare, Kyoto, Japan), was measured twice consecutively with subjects in the sitting position, with a minimum 2-min rest between measurements. The mean of the two measured values was used for analysis.
Devices used to measure ABP or CBP met the criteria of the Association for the Advancement of Medical Instrumentation. [24] [25] [26] Hypertension was defined as 24-h systolic blood pressure (SBP) ≥135 mm Hg and/or 24-h DBP ≥80 mm Hg and/or use of antihypertensive medications. 27 Patients with secondary hypertension could be included in this study.
Biochemical parameters such as serum electrolytes and serum creatinine levels were measured with an autoanalyzer.
Genetic analysis. Genomic DNA samples were extracted from peripheral leukocytes of participants. In the first step of the study, we randomly selected 60 women from the 755 women, amplified the (P)RR gene by PCR and sequenced the PCR products. The promoter region and each exon, including an adjacent intron of the (P)RR gene, were amplified by PCR with primers summarized in Supplementary Table S1 online. The PCR products were purified using a PCR purification kit (BIONEX, Seoul, Korea) and directly sequenced with an auto sequencer (ABI PRISM 3100; Applied Biosystems, Foster, CA). We calculated D′ and r 2 values to estimate the linkage-disequilibrium in pairwise combinations of each polymorphism.
In the second step, based on the results of the linkagedisequilibrium analyses on the 60 women, three singlenucleotide polymorphisms (SNPs) were genotyped in the total population (n = 1,112) containing the 60 women studied in the first step, as follows: −782A>G (rs2968915) in the promoter region, intervening sequence (IVS)5+169C>T (rs5918007) in intron5, and +1513A>G (rs6609080) in the 3′-untranslated region. −782A>G was genotyped by direct sequence method described above. IVS5+169C>T and +1513A>G were genotyped by PCR-restriction fragment length polymorphism method with FokI and BsmI, respectively. The region of genomic DNA including each SNP was amplified with primers summarized in Supplementary Table S1 online. The PCR products were digested, analyzed by electrophoresis in 5% polyacrylamide gel, and visualized under UV light.
Statistical analysis. Statistical analysis was performed with the JMP 5.0.1 statistical software package (SAS Institute, Cary, NC). Because the (P)RR gene is on the X chromosome, men (n = 357) and women (n = 755) were analyzed separately. The Student t-test, χ 2 -test, analysis of variance, and analysis of covariance were used where appropriate. The analysis of covariance model included the following traditional risk factors and covariates for blood pressure levels: age, body mass index (BMI), use of antihypertensive medications, prevalence of diabetes mellitus, history of previous cardiovascular disease, current smoking, and current drinking. Multiple comparisons were performed with Tukey-Kramer's test. Multiple regression analysis was used to determine whether (P)RR gene polymorphisms predicted blood pressure values after adjustment for the traditional risk factors and covariates for blood pressure levels. Continuous values were expressed as mean ± s.d. Differences of P < 0.05 were considered statistically significant. Furthermore, we applied Bonferroni correction, because we conducted tests on three SNPs in two sexes against eight blood pressure traits (48 statistical tests). Differences of P < 0.001 (= 0.05/48) were considered statistically significant after Bonferroni correction.
results

Polymorphisms in the (P)RR gene
We identified 11 SNPs in the (P)RR gene in the 60 women sequenced (Figure 1, Table 1 ). −1024T>C and IVS5+1006G>A are new variants that have not been reported in the SNP database of the National Center for Biotechnology Information, but that showed a low frequency (1.7% for each). Other SNPs had already been registered, and were detected at a frequency articles (Pro)renin Receptor and Blood Pressure of >10%. Although four coding mutations (F30L, P43A, P90A, and A290P) have been registered in the National Center for Biotechnology Information database, no SNP had an amino acid substitution in these 60 Japanese women.
Linkage-disequilibrium analysis revealed that the (P)RR gene had three complete linkage-disequilibrium regions (D′ = 1.00; r 2 = 1.00): −1507C>A and −782A>G; IVS5+45C>G and IVS5+169C>T; and +867T>C, +1421A>T, +1513A>G, +1916A>G, and +1964T>C. In addition, −1507C>A (and −782A>G) and IVS5+45C>G (and IVS5+169C>T) were in tight linkage-disequilibrium (D′ = 1.00; r 2 = 0.86), and IVS5+45C>G (and IVS5+169C>T) and +867T>C (+1421A>T, +1513A>G, +1916A>G, and +1964T>C) were in weak linkagedisequilibrium (D′ = 1.00; r 2 = 0.05). Based on the linkagedisequilibrium analyses, we selected −782A>G, IVS5+169C>T, or +1513A>G from each complete linkage-disequilibrium region for the association study.
The genotype frequencies of each SNP in the total population are shown in Supplementary Table S2 online. The genotype frequencies of each SNP were consistent with the Hardy-Weinberg equilibrium in women (as the (P)RR gene is located on the X chromosome, genotype data were omitted in men), and there were no significant differences in allele frequencies between men and women.
association study
All clinical characteristics, including age, BMI, use of antihypertensive medications, prevalence of hypertension, history of previous cardiovascular disease, and blood pressure values were significantly different between men and women ( Table 2) .
IVS5+169C>T was significantly associated with ABP in men ( Table 3) . The blood pressure values in IVS5+169T allele carriers were significantly higher than in C allele carriers (24-h SBP: P < 0.001, 24-h DBP: P < 0.001, daytime SBP: P = 0.004, daytime DBP: P = 0.006, nighttime SBP: P < 0.001, nighttime DBP: P < 0.001). After the Bonferroni correction, the associations with 24-h SBP, 24-h DBP, nighttime SBP, and nighttime DBP remained significant. Although adjustment applied for age, BMI, use of antihypertensive medications, prevalence of diabetes mellitus, history of previous cardiovascular disease, current smoking, and current drinking, the associations with nighttime SBP (P < 0.001) and nighttime DBP (P < 0.001) remained significant, but the associations with 24-h SBP (P = 0.006), 24-h DBP (P = 0.003), daytime SBP (P = 0.02) and daytime DBP (P = 0.02) were borderline significance. On the other hand, no significant differences were observed in CBP between the two alleles of IVS5+169C>T. A higher prevalence of hypertensive subjects was observed in subjects with the T allele (61.7%) than in those with the C allele (49.4%), but the difference was not significant (P = 0.1). There were no significant differences in clinical characteristics and biochemical parameters such as age, BMI, use of antihypertensive medications, history of previous cardiovascular disease, Na, K, and serum creatinine between the two alleles of IVS5+169C>T. In women, there were no significant differences in blood pressure and prevalence of hypertension (Supplementary Table S3B Human (P)RR gene (Xp11.4) TT) or recessive model (CC vs. CT+TT), no significant differences were observed in those parameters between the two groups. −782A>G was also associated with ABP in men, but P values were higher than those of IVS5+169C>T (24-h SBP: P = 0.02, 24-h DBP: P = 0.03, daytime SBP: P = 0.04, daytime DBP: P = 0.08, nighttime SBP: P = 0.01, nighttime DBP: P = 0.01; Supplementary Table S3A online). +1513A>G was not associated with blood pressure in men or women (Supplementary Table S3C online) . Multiple regression analysis of nighttime SBP in men showed that IVS5+169C>T was significantly and independently related to ABP (β = 5.754, P < 0.001) after adjustment for traditional covariates including age, BMI, use of antihypertensive medications, prevalence of diabetes mellitus, history of previous cardiovascular disease, current smoking, and current drinking ( Table 4) . Moreover, the same relation was observed after multiple regression analysis of nighttime DBP (β = 3.822, P < 0.001). Whereas IVS5+169C>T was borderline significance in multiple regression analysis for ABP of 24-h SBP (β = 5.023, P = 0.006), 24-h DBP (β = 3.272, P = 0.003), daytime SBP (β = 4.510, P = 0.02), and daytime DBP (β = 2.864, P = 0.02).
Finally, we reconstructed haplotypes from the three SNPs (−782A>G, IVS5+169C>T, and +1513A>G) to examine the association of haplotypes with hypertensive parameters such as blood pressure values and prevalence of hypertension. No significant associations were observed in men or women.
discussion
This study has shown for the first time the potential importance of the (P)RR gene in blood pressure regulation in humans. In men, the T allele of IVS5+169C>T in the (P)RR gene was associated with a significantly higher ABP than the C allele. The blood pressure difference of 6.4 mm Hg in 24-h SBP is higher than values found in previous reports on the association between blood pressure and polymorphisms of hypertensive genes such as angiotensin-converting enzyme gene I/D (3.4 mm Hg difference in SBP) 28 and angiotensinogen gene M235T (1.4 mm Hg difference in SBP). 29 The association between −782A>G and ABP was also observed. Because −782A>G was in tight linkage-disequilibrium with IVS5+169C>T, the association of IVS5+169C>T with ABP affects that of −782A>G. Thus, the IVS5+169C>T locus seems to be the major relevant determinant of blood pressure value.
Moreover, IVS5+169C>T was more closely and strongly related to nighttime blood pressure values than 24-h and daytime blood pressure values. It is not clear why the IVS5+169C>T was more closely related to nighttime blood pressure than daytime blood pressure. The (P)RR is abundantly present in brain. Shan et al. have shown that (P)RR blockade by handle region peptide significantly inhibited the renin-induced decrease in neuronal activity. 30 Therefore, it is possible that the (P)RR in the brain may have a certain role in the relation more closely to nighttime blood pressure than daytime blood pressure. Several studies have shown that nighttime blood pressure is superior to daytime blood pressure in predicting target organ damage and prognosis. [31] [32] [33] Therefore, IVS5+169T allele carriers who have elevated nighttime blood pressure may have an increased risk for cardiovascular events or progression to end organ damage.
In contrast to ABP, IVS5+169C>T was not associated with CBP. CBP usually does not reflect basal blood pressure, but is susceptible to physical or psychological stress and environmental factors. Therefore, ABP may reflect basal blood pressure better than CBP, and is an indicator of a patient's "true" articles (Pro)renin Receptor and Blood Pressure blood pressure. 34 These findings suggest that IVS5+169C>T may affect basal blood pressure regulation and be related to hypertensive organ damage. In contrast to men, no significant association was observed in women between IVS5+169C>T and blood pressure. Several possible mechanisms may explain this gender-specific association. First, the random expression of chromosome X, which is called the "Lyon hypothesis, " 35 may be related to this gender-specific effect. Second, sex hormones such as testosterone and estrogen affect (P)RR. 36 In addition, gender-specific effects of polymorphisms of RAS components were reported previously. 37, 38 Therefore, the effect of (P)RR on blood pressure may also be influenced by sex hormones. Third, large differences in clinical characteristics between the men and women in this study may have affected the gender-specific association.
The biological mechanism by which the IVS5+169C>T polymorphism is associated with blood pressure is unclear. An effect on alternative splicing of the primary mRNA transcript to generate a different protein may be involved. It was reported that a silent mutation in exon4 of the human (P)RR gene (c321C>T, p.D107D) enhanced the expression of (P)RR that lacked exon4, and this mutant receptor could bind to renin and increase renin catalytic activity, similar to the wild-type receptor but resulting in a modest and reproducible impairment of ERK1/2 activation. 39 In our laboratory, splice variants lacking exon4 or both exon4 and exon5 were also observed (data not shown). As IVS5+169C>T and IVS5+45C>G were close to the exon5 and intron5 boundary, these SNPs might affect splicing activity to induce alternative splicing in the region near exon4 and exon5. However, there are no data as of yet to support the hypothesis that the variant in question affects the process leading to such alternative forms of the (P)RR.
This study has some limitations. Schefe et al. demonstrated the downregulation of (P)RR by renin and prorenin. 40, 41 Susic et al. recently showed that dietary sodium may reduce the contribution of (P)RR to hypertensive cardiac hypertrophy, although handle region peptide has a benefit in either SHR fed a normal salt diet or SHR fed a high-salt diet. 42 However, we could not evaluate the influence of these biological parameters on the association of (P)RR polymorphism with blood pressure in this study, because they were not measured in most participants in this study. There are no functional studies to substantiate why IVS5+169C>T might raise blood pressure, nor data on why the association should be sex-specific. Furthermore, the results might be affected by complex and relative interactions in the balance between genes and environment. Therefore, another replication study with a more sophisticated study design, including a larger sample size, different ethnic groups, longitudinal surveillance, and functional analysis, should help clarify the role of (P)RR gene polymorphisms in blood pressure regulation.
To our knowledge, this is the first report to show the association of (P)RR with blood pressure in humans. Only the association between IVS+169C>T and nighttime SBP and DBP in men remained significant after Bonferroni correction. Whether the associations will prove to stand up to further genetic studies remains to be seen. These will be required in different settings before we reach a final conclusion. Nevertheless, we believe that the study is a good start and may encourage research by others.
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